Search

Your search keyword '"Trapolin, Gaia"' showing total 2 results
Start Over Author "Trapolin, Gaia"
2 results on '"Trapolin, Gaia"'

1. ALLiance for sEcondary PREvention after an acute coronary syndrome. The ALLEPRE trial: A multicenter fully nurse-coordinated intensive intervention program

Author

Paoli, Giorgia, Notarangelo, Maria Francesca, Mattioli, Maria, La Sala, Rachele, Foà, Chiara, Solinas, Emilia, Fusco, Sara, Fava, Cristian, Caminiti, Caterina, Artioli, Giovanna, Pelà, Giovanna, Dall’Aglio, Elisabetta, Manari, Antonio, Tondi, Stefano, Rizzo, Antonio, Trapolin, Gaia, Patrizi, Giampiero, Cappelli, Stefano, Villani, Giovanni Quinto, Piepoli, Massimo, Zobbi, Gianni, Nicosia, Elisa, and Ardissino, Diego

Published
2018
Full Text
View/download PDF

2. Delayed profound thrombocytopenia after abciximab administration for coronary stenting in acute coronary syndrome. Case reports and review of the literature.

Author

Trapolin G, Savonitto S, Merlini PA, Caimi MT, and Klugmann S

Subjects
Abciximab, Adrenal Cortex Hormones therapeutic use, Angioplasty, Balloon, Coronary instrumentation, Angioplasty, Balloon, Coronary methods, Antibodies, Monoclonal therapeutic use, Anticoagulants therapeutic use, Coronary Angiography, Follow-Up Studies, Humans, Immunoglobulin Fab Fragments therapeutic use, Male, Middle Aged, Myocardial Infarction diagnostic imaging, Plasmapheresis methods, Platelet Count, Risk Assessment, Severity of Illness Index, Thrombocytopenia therapy, Time Factors, Antibodies, Monoclonal adverse effects, Anticoagulants adverse effects, Immunoglobulin Fab Fragments adverse effects, Myocardial Infarction therapy, Stents adverse effects, Thrombocytopenia chemically induced
Abstract

Profound thrombocytopenia occurring 1 week after drug administration is a seldom described, self-limiting and mostly uneventful immune reaction to abciximab. Quick differential diagnosis is essential, since other forms of thrombocytopenia associated with concomitant antithrombotic therapies may be much more severe and require prompt treatment. Awareness of this reaction may avoid unnecessary and risky discontinuation of other antiplatelet therapies in the critical phase after coronary stenting.

Published
2005

Catalog

Books, media, physical & digital resources
See catalog results